Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Awareness to Action: Transforming Proton Pump Inhibitor Use in Ras Al Khaimah Through Education and Intervention: the RAK -PRIDE Study

NCT06858384 is registered in ClinicalTrials.gov with RAK Medical and Health Sciences University as lead sponsor.

NCT NCT06858384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06858384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Awareness to Action: Transforming Proton Pump Inhibitor Use in Ras Al Khaimah Through Education and Intervention: the RAK -PRIDE Study
Lead sponsor
RAK Medical and Health Sciences University
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2025
Completion date
February 28, 2026
Enrollment
479 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deprescribing, inappropriate use, proton pump inhibitors